{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"columns":[{"gene":"","key":"MONDO:0018591/ORPHA:439254","label":"ITM2B amyloidosis","mondoId":"MONDO:0018591","onsetQualifier":null,"recordKeys":["0c022641446046562c8a33e7247cdb5b22000828467d5cea1739b0517da873b9","278e9422de855e6c8eb3f5ff043244ca7094d0a016be144490aae77291d3b434","861e00638b4ef2f515a04565964d91396f99724571323e8968c31e075bdcd9bb","b61434b85901fc0884172827266376bc0954ad46b8b4955680190ec25f5415cc","b63641ef9c2e2396f045593b57fa36d6cc9fe707acb820859e4b64d5f3824e8f","cc255fbeaafef0d88128145ff8083ef603e4b9b96fafed919ef9c6ced6f1488f","d4aed3f7e34fc8ede030a9349fb3396fc58cccf49f4e46a0a5741d3fc8523567","f227815ba1e36813203d02defcd004a3d7965831d0532923822ce47e2ae126b7"],"recordQualifiers":{},"scopeLabel":"ORPHA:439254","sourceIds":["ORPHA:439254"],"sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"comparison":{"collapseColumnsLabel":"Show initial comparisons","defaultColumnKeys":["MONDO:0018591/ORPHA:439254"],"expandColumnsLabel":"Compare all source entries","intro":"Compare the original source entries. Different entries may describe different patient groups.","primaryFeatureIds":[],"scopeNoteHtml":"<p>Each column keeps its native condition scope. Initial features are displayed alphabetically, not ranked by clinical importance. Counts remain separate, and an empty cell does not mean a feature cannot occur.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":8,"sourceGroups":{"omim":0,"orphanet":8,"published":0}},"features":[{"hpoId":"HP:0000518","label":"Cataract","primary":false},{"hpoId":"HP:0011970","label":"Cerebral amyloid angiopathy","primary":false},{"hpoId":"HP:0000726","label":"Dementia","primary":false},{"hpoId":"HP:0000365","label":"Hearing loss","primary":false},{"hpoId":"HP:0002352","label":"Leukoencephalopathy","primary":false},{"hpoId":"HP:0002185","label":"Neurofibrillary tangles","primary":false},{"hpoId":"HP:0002073","label":"Progressive cerebellar ataxia","primary":false},{"hpoId":"HP:0001285","label":"Spastic tetraparesis","primary":false}],"ledeHtml":"A patient-friendly description is not yet available in the ingested narrative sources for this condition.","mondoId":"MONDO:0018591","records":[{"frequencyKind":"range","key":"0c022641446046562c8a33e7247cdb5b22000828467d5cea1739b0517da873b9","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:439254","disease_name":"ITM2B amyloidosis","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001285","is_excluded":false,"label":"Spastic tetraparesis","onset_id":null,"reference":"ORPHA:439254","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"278e9422de855e6c8eb3f5ff043244ca7094d0a016be144490aae77291d3b434","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:439254","disease_name":"ITM2B amyloidosis","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002352","is_excluded":false,"label":"Leukoencephalopathy","onset_id":null,"reference":"ORPHA:439254","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"861e00638b4ef2f515a04565964d91396f99724571323e8968c31e075bdcd9bb","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:439254","disease_name":"ITM2B amyloidosis","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000518","is_excluded":false,"label":"Cataract","onset_id":null,"reference":"ORPHA:439254","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"b61434b85901fc0884172827266376bc0954ad46b8b4955680190ec25f5415cc","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:439254","disease_name":"ITM2B amyloidosis","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000726","is_excluded":false,"label":"Dementia","onset_id":null,"reference":"ORPHA:439254","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"b63641ef9c2e2396f045593b57fa36d6cc9fe707acb820859e4b64d5f3824e8f","raw":{"aspect":"P","body_system":"ear","disease_id":"ORPHA:439254","disease_name":"ITM2B amyloidosis","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000365","is_excluded":false,"label":"Hearing impairment","onset_id":null,"reference":"ORPHA:439254","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"cc255fbeaafef0d88128145ff8083ef603e4b9b96fafed919ef9c6ced6f1488f","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:439254","disease_name":"ITM2B amyloidosis","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002073","is_excluded":false,"label":"Progressive cerebellar ataxia","onset_id":null,"reference":"ORPHA:439254","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"d4aed3f7e34fc8ede030a9349fb3396fc58cccf49f4e46a0a5741d3fc8523567","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:439254","disease_name":"ITM2B amyloidosis","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0011970","is_excluded":false,"label":"Cerebral amyloid angiopathy","onset_id":null,"reference":"ORPHA:439254","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"f227815ba1e36813203d02defcd004a3d7965831d0532923822ce47e2ae126b7","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:439254","disease_name":"ITM2B amyloidosis","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002185","is_excluded":false,"label":"Neurofibrillary tangles","onset_id":null,"reference":"ORPHA:439254","source_release":"2026-06-23"},"sourceGroups":["orphanet"]}],"referenceLabels":{},"references":{"causeHtml":"<p>No mapped MedlinePlus condition document in this snapshot.</p>","identityNote":"MONDO defines condition identity and route membership. Native evidence populations and narrative coverage retain their separate scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>No MedlinePlus narrative has been mapped to this MONDO condition. Feature annotations, when available, are retained below.</p>","key":"overview","title":"Condition overview"}],"sharedSources":[],"slug":"itm2b-amyloidosis","sourceDocuments":[],"sourceNote":"MONDO condition identity; scoped MedlinePlus enrichment where available; original HPO annotations.","takeawayHtml":"Cause information is not available in the mapped narrative sources for this condition.","title":"ITM2B amyloidosis"},"schemaVersion":1}